Novel antipsychotics and patient care in state hospitals

Peter F Buckley

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

OBJECTIVE: To review and highlight the opportunities and challenges of pharmacologic advances in the use of antipsychotics for the state hospital system. METHODS: A critical review was performed of studies published either as articles or abstracts, on the use of novel antipsychotics, particularly as they relate to the patient population within the state mental hospital system. FINDINGS: The recent availability of new antipsychotic medications within state facilities has resulted in more progressive treatment, reduced recidivism (and consequently cost savings), and preliminary evidence of preferential and superior treatment response in specific patient subgroups (e.g., those with aggression). At the same time, inpatient pharmacy budget increases and uncertainty in guiding the use of novel antipsychotics have influenced the availability of these agents in state hospitals. CONCLUSIONS: State hospital services have, by and large, embraced the developments in pharmacotherapy of schizophrenia. Optimal use of these new agents in this population requires additional information on their relative efficacy in specific patient subgroups.

Original languageEnglish (US)
Pages (from-to)906-914
Number of pages9
JournalAnnals of Pharmacotherapy
Volume32
Issue number9
DOIs
StatePublished - Sep 1 1998

Fingerprint

State Hospitals
Antipsychotic Agents
Patient Care
Cost Savings
Psychiatric Hospitals
Budgets
Aggression
Population
Uncertainty
Inpatients
Schizophrenia
Drug Therapy
Therapeutics

Keywords

  • Antipsychotics
  • State hospitals

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Novel antipsychotics and patient care in state hospitals. / Buckley, Peter F.

In: Annals of Pharmacotherapy, Vol. 32, No. 9, 01.09.1998, p. 906-914.

Research output: Contribution to journalReview article

Buckley, Peter F. / Novel antipsychotics and patient care in state hospitals. In: Annals of Pharmacotherapy. 1998 ; Vol. 32, No. 9. pp. 906-914.
@article{dfcbcee0ac8342459bd62042e20ced20,
title = "Novel antipsychotics and patient care in state hospitals",
abstract = "OBJECTIVE: To review and highlight the opportunities and challenges of pharmacologic advances in the use of antipsychotics for the state hospital system. METHODS: A critical review was performed of studies published either as articles or abstracts, on the use of novel antipsychotics, particularly as they relate to the patient population within the state mental hospital system. FINDINGS: The recent availability of new antipsychotic medications within state facilities has resulted in more progressive treatment, reduced recidivism (and consequently cost savings), and preliminary evidence of preferential and superior treatment response in specific patient subgroups (e.g., those with aggression). At the same time, inpatient pharmacy budget increases and uncertainty in guiding the use of novel antipsychotics have influenced the availability of these agents in state hospitals. CONCLUSIONS: State hospital services have, by and large, embraced the developments in pharmacotherapy of schizophrenia. Optimal use of these new agents in this population requires additional information on their relative efficacy in specific patient subgroups.",
keywords = "Antipsychotics, State hospitals",
author = "Buckley, {Peter F}",
year = "1998",
month = "9",
day = "1",
doi = "10.1345/aph.17409",
language = "English (US)",
volume = "32",
pages = "906--914",
journal = "Annals of Pharmacotherapy",
issn = "1060-0280",
publisher = "Harvey Whitney Books Company",
number = "9",

}

TY - JOUR

T1 - Novel antipsychotics and patient care in state hospitals

AU - Buckley, Peter F

PY - 1998/9/1

Y1 - 1998/9/1

N2 - OBJECTIVE: To review and highlight the opportunities and challenges of pharmacologic advances in the use of antipsychotics for the state hospital system. METHODS: A critical review was performed of studies published either as articles or abstracts, on the use of novel antipsychotics, particularly as they relate to the patient population within the state mental hospital system. FINDINGS: The recent availability of new antipsychotic medications within state facilities has resulted in more progressive treatment, reduced recidivism (and consequently cost savings), and preliminary evidence of preferential and superior treatment response in specific patient subgroups (e.g., those with aggression). At the same time, inpatient pharmacy budget increases and uncertainty in guiding the use of novel antipsychotics have influenced the availability of these agents in state hospitals. CONCLUSIONS: State hospital services have, by and large, embraced the developments in pharmacotherapy of schizophrenia. Optimal use of these new agents in this population requires additional information on their relative efficacy in specific patient subgroups.

AB - OBJECTIVE: To review and highlight the opportunities and challenges of pharmacologic advances in the use of antipsychotics for the state hospital system. METHODS: A critical review was performed of studies published either as articles or abstracts, on the use of novel antipsychotics, particularly as they relate to the patient population within the state mental hospital system. FINDINGS: The recent availability of new antipsychotic medications within state facilities has resulted in more progressive treatment, reduced recidivism (and consequently cost savings), and preliminary evidence of preferential and superior treatment response in specific patient subgroups (e.g., those with aggression). At the same time, inpatient pharmacy budget increases and uncertainty in guiding the use of novel antipsychotics have influenced the availability of these agents in state hospitals. CONCLUSIONS: State hospital services have, by and large, embraced the developments in pharmacotherapy of schizophrenia. Optimal use of these new agents in this population requires additional information on their relative efficacy in specific patient subgroups.

KW - Antipsychotics

KW - State hospitals

UR - http://www.scopus.com/inward/record.url?scp=0031691842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031691842&partnerID=8YFLogxK

U2 - 10.1345/aph.17409

DO - 10.1345/aph.17409

M3 - Review article

C2 - 9762379

AN - SCOPUS:0031691842

VL - 32

SP - 906

EP - 914

JO - Annals of Pharmacotherapy

JF - Annals of Pharmacotherapy

SN - 1060-0280

IS - 9

ER -